International Ophthalmology

, Volume 35, Issue 4, pp 595–597 | Cite as

IgG4-related disease mimicking chalazion in the upper eyelid with skin manifestations on the trunk

  • Tiina LeivoEmail author
  • Sari Koskenmies
  • Marita Uusitalo
  • Olli Tynninen
Case Report


IgG4-related disease is a recently defined inflammatory process characterized by IgG4-bearing plasma cells in the involved tissues. The most common sites of involvement are the pancreas, hepatobiliary tract, salivary glands, lymph nodes, retroperitoneum and orbit, especially the lacrimal glands. Other ocular or ocular adnexal sites are rare. To our knowledge, there is one reported case of a conjunctival involvement. We describe a patient, who had an IgG4-RD mimicking chalazion in the upper eyelid, confined to the tarsus, with multiple skin lesions on the trunk. This is a case report of a 55-year-old female. A 55-year-old female presented with an upper eyelid lesion, which was clinically diagnosed as chalazion and drained three times. Histopathological diagnoses were chalazion and inflammation with mixed cells, respectively. Additionally, the patient had had skin nodules on the trunk for several years. Finally, after a third recurrence, the tarsal eyelid lesion was completely excised. The tarsal pathology specimen showed 85 IgG4 positive plasma cells per HPF and the IgG4/IgG ratio was 0.64, suggesting a probable IgG4-related disease. The re-examined skin lesions resembled histologically the eyelid lesion. It is essential to be aware of IgG4-related disease, including in recurrent chalazia.


IgG4-related disease Ocular Skin Chalazion Eyelid 


Conflict of interest

None of the authors have conflict of interest with the submission.


  1. 1.
    Andrew N, Kearney D, Selva D (2013) IgG4-related disease: a meta-analysis and review. Acta Ophthalmol 91:694–700PubMedCrossRefGoogle Scholar
  2. 2.
    da Fonseca FL, Ramos Rde I, de Lima PP, Noguiera AB, Matayoshi S (2013) Unilateral eyelid mass as unusual presentation of ocular adnexal IgG4-related inflammation. Cornea 32(4):517–519PubMedCrossRefGoogle Scholar
  3. 3.
    Ikeda T, Oka M, Shimizu H, Hatakeyama M, Kanki H, Kunisada M, Tsuji G, Morinobu A, Kumagai S, Azumi A, Negi A, Nishigori C (2013) IgG4-related skin manifestations in patients with IgG4-related disease. Eur J Dermatol 23(2):241–245. doi: 10.1684/ejd.2013.1958 PubMedGoogle Scholar
  4. 4.
    Kempeneers D, Hauben E, De Haes P (2014) IgG4-related skin lesions: case report and review of the literature. Clin Exp Dermatol 39(4):479–483. doi: 10.1111/ced.12325 Epub 2014 Apr 23PubMedCrossRefGoogle Scholar
  5. 5.
    Umehara H, Okazaki K, Masaki Y et al (2011) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD). Mod Rheumatol 22:21–30CrossRefGoogle Scholar
  6. 6.
    Deshpande V, Zen Y, Chan JK et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181–1192PubMedCrossRefGoogle Scholar
  7. 7.
    Yamamoto M, Takahashi H, Tabeya T et al (2012) Risk of malignancies in IgG4-related disease. Mod Rheumatol 22:414–418PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  • Tiina Leivo
    • 1
    Email author
  • Sari Koskenmies
    • 2
  • Marita Uusitalo
    • 1
  • Olli Tynninen
    • 3
  1. 1.Helsinki University Eye HospitalHelsinkiFinland
  2. 2.Helsinki University Skin and Allergy HospitalHelsinkiFinland
  3. 3.Department of PathologyUniversity of HelsinkiHelsinkiFinland

Personalised recommendations